Skip Navigation

A Phase I/Ib Dose Escalation Study of Abemaciclib and Olaparib for Recurrent Platinum- Resistant Ovarian Cancer

Brief Summary

Type:
Ovarian

Study Type:
Treatment

Phase:
I

ClinicalTrials.gov Identifier:
NCT04633239

Study #:
STUDY00150622

Start Date:
Nov 08, 2023

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT04633239

View Complete Trial Details & Eligibility at ClinicalTrials.gov